Global Antihypertensive Drugs Market Research Report 2017

Publisher Name :
Date: 04-Oct-2017
No. of pages: 116
Inquire Before Buying

In this report, the global Antihypertensive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antihypertensive Drugs in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Antihypertensive Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- Novartis

- Pfizer

- Johnson & Johnson

- Sanofi

- Lupin

- Ranbaxy Laboratories

- Merck

- Astra Zeneca

- Daiichi Sankyo

- Takeda

- Actelion

- United Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- ARB

- CCB

- Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Antihypertensive Drugs for each application, including

- Hypertension

- PAH

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Antihypertensive Drugs Market Research Report 2017

Table of Contents
Global Antihypertensive Drugs Market Research Report 2017
1 Antihypertensive Drugs Market Overview
1.1 Product Overview and Scope of Antihypertensive Drugs
1.2 Antihypertensive Drugs Segment by Type (Product Category)
1.2.1 Global Antihypertensive Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Antihypertensive Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 ARB
1.2.4 CCB
1.2.5 Other
1.3 Global Antihypertensive Drugs Segment by Application
1.3.1 Antihypertensive Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hypertension
1.3.3 PAH
1.3.4 Other
1.4 Global Antihypertensive Drugs Market by Region (2012-2022)
1.4.1 Global Antihypertensive Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Antihypertensive Drugs (2012-2022)
1.5.1 Global Antihypertensive Drugs Revenue Status and Outlook (2012-2022)
1.5.2 Global Antihypertensive Drugs Capacity, Production Status and Outlook (2012-2022)
2 Global Antihypertensive Drugs Market Competition by Manufacturers
2.1 Global Antihypertensive Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Antihypertensive Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Antihypertensive Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Antihypertensive Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Antihypertensive Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Antihypertensive Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antihypertensive Drugs Market Competitive Situation and Trends
2.5.1 Antihypertensive Drugs Market Concentration Rate
2.5.2 Antihypertensive Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Antihypertensive Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Antihypertensive Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Antihypertensive Drugs Production and Market Share by Region (2012-2017)
3.3 Global Antihypertensive Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Antihypertensive Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Antihypertensive Drugs Consumption by Region (2012-2017)
4.2 North America Antihypertensive Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Antihypertensive Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Antihypertensive Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Antihypertensive Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Antihypertensive Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Antihypertensive Drugs Production, Consumption, Export, Import (2012-2017)
5 Global Antihypertensive Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Antihypertensive Drugs Production and Market Share by Type (2012-2017)
5.2 Global Antihypertensive Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Antihypertensive Drugs Price by Type (2012-2017)
5.4 Global Antihypertensive Drugs Production Growth by Type (2012-2017)
6 Global Antihypertensive Drugs Market Analysis by Application
6.1 Global Antihypertensive Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Antihypertensive Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Antihypertensive Drugs Manufacturers Profiles/Analysis
7.1 Novartis
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Antihypertensive Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Novartis Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Pfizer
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Antihypertensive Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Pfizer Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Johnson & Johnson
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Antihypertensive Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Johnson & Johnson Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Sanofi
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Antihypertensive Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Sanofi Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Lupin
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Antihypertensive Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Lupin Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Ranbaxy Laboratories
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Antihypertensive Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Ranbaxy Laboratories Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Merck
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Antihypertensive Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Merck Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Astra Zeneca
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Antihypertensive Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Astra Zeneca Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Daiichi Sankyo
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Antihypertensive Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Daiichi Sankyo Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Takeda
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Antihypertensive Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Takeda Antihypertensive Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Actelion
7.12 United Therapeutics
8 Antihypertensive Drugs Manufacturing Cost Analysis
8.1 Antihypertensive Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antihypertensive Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Antihypertensive Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Antihypertensive Drugs Market Forecast (2017-2022)
12.1 Global Antihypertensive Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Antihypertensive Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Antihypertensive Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Antihypertensive Drugs Price and Trend Forecast (2017-2022)
12.2 Global Antihypertensive Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Antihypertensive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Antihypertensive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Antihypertensive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Antihypertensive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Antihypertensive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Antihypertensive Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Antihypertensive Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Antihypertensive Drugs Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Antihypertensive Drugs
Figure Global Antihypertensive Drugs Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Antihypertensive Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of ARB
Table Major Manufacturers of ARB
Figure Product Picture of CCB
Table Major Manufacturers of CCB
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Antihypertensive Drugs Consumption (K MT) by Applications (2012-2022)
Figure Global Antihypertensive Drugs Consumption Market Share by Applications in 2016
Figure Hypertension Examples
Table Key Downstream Customer in Hypertension
Figure PAH Examples
Table Key Downstream Customer in PAH
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Antihypertensive Drugs Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2012-2022)
Figure North America Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Antihypertensive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Antihypertensive Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Antihypertensive Drugs Capacity, Production (K MT) Status and Outlook (2012-2022)
Figure Global Antihypertensive Drugs Major Players Product Capacity (K MT) (2012-2017)
Table Global Antihypertensive Drugs Capacity (K MT) of Key Manufacturers (2012-2017)
Table Global Antihypertensive Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Antihypertensive Drugs Capacity (K MT) of Key Manufacturers in 2016
Figure Global Antihypertensive Drugs Capacity (K MT) of Key Manufacturers in 2017
Figure Global Antihypertensive Drugs Major Players Product Production (K MT) (2012-2017)
Table Global Antihypertensive Drugs Production (K MT) of Key Manufacturers (2012-2017)
Table Global Antihypertensive Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Antihypertensive Drugs Production Share by Manufacturers
Figure 2017 Antihypertensive Drugs Production Share by Manufacturers
Figure Global Antihypertensive Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Antihypertensive Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Antihypertensive Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Antihypertensive Drugs Revenue Share by Manufacturers
Table 2017 Global Antihypertensive Drugs Revenue Share by Manufacturers
Table Global Market Antihypertensive Drugs Average Price (USD/MT) of Key Manufacturers (2012-2017)
Figure Global Market Antihypertensive Drugs Average Price (USD/MT) of Key Manufacturers in 2016
Table Manufacturers Antihypertensive Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Antihypertensive Drugs Product Category
Figure Antihypertensive Drugs Market Share of Top 3 Manufacturers
Figure Antihypertensive Drugs Market Share of Top 5 Manufacturers
Table Global Antihypertensive Drugs Capacity (K MT) by Region (2012-2017)
Figure Global Antihypertensive Drugs Capacity Market Share by Region (2012-2017)
Figure Global Antihypertensive Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Antihypertensive Drugs Capacity Market Share by Region
Table Global Antihypertensive Drugs Production by Region (2012-2017)
Figure Global Antihypertensive Drugs Production (K MT) by Region (2012-2017)
Figure Global Antihypertensive Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Antihypertensive Drugs Production Market Share by Region
Table Global Antihypertensive Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Antihypertensive Drugs Revenue Market Share by Region (2012-2017)
Figure Global Antihypertensive Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Antihypertensive Drugs Revenue Market Share by Region
Figure Global Antihypertensive Drugs Capacity, Production (K MT) and Growth Rate (2012-2017)
Table Global Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table North America Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Europe Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table China Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Japan Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Southeast Asia Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table India Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Global Antihypertensive Drugs Consumption (K MT) Market by Region (2012-2017)
Table Global Antihypertensive Drugs Consumption Market Share by Region (2012-2017)
Figure Global Antihypertensive Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Antihypertensive Drugs Consumption (K MT) Market Share by Region
Table North America Antihypertensive Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Europe Antihypertensive Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table China Antihypertensive Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Japan Antihypertensive Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Southeast Asia Antihypertensive Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table India Antihypertensive Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
Table Global Antihypertensive Drugs Production (K MT) by Type (2012-2017)
Table Global Antihypertensive Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Antihypertensive Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Antihypertensive Drugs by Type
Table Global Antihypertensive Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Antihypertensive Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Antihypertensive Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Antihypertensive Drugs by Type
Table Global Antihypertensive Drugs Price (USD/MT) by Type (2012-2017)
Figure Global Antihypertensive Drugs Production Growth by Type (2012-2017)
Table Global Antihypertensive Drugs Consumption (K MT) by Application (2012-2017)
Table Global Antihypertensive Drugs Consumption Market Share by Application (2012-2017)
Figure Global Antihypertensive Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Antihypertensive Drugs Consumption Market Share by Application in 2016
Table Global Antihypertensive Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Antihypertensive Drugs Consumption Growth Rate by Application (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Novartis Antihypertensive Drugs Production Market Share (2012-2017)
Figure Novartis Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Pfizer Antihypertensive Drugs Production Market Share (2012-2017)
Figure Pfizer Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Johnson & Johnson Antihypertensive Drugs Production Market Share (2012-2017)
Figure Johnson & Johnson Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Sanofi Antihypertensive Drugs Production Market Share (2012-2017)
Figure Sanofi Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Lupin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lupin Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lupin Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Lupin Antihypertensive Drugs Production Market Share (2012-2017)
Figure Lupin Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Ranbaxy Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ranbaxy Laboratories Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Ranbaxy Laboratories Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Ranbaxy Laboratories Antihypertensive Drugs Production Market Share (2012-2017)
Figure Ranbaxy Laboratories Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Merck Antihypertensive Drugs Production Market Share (2012-2017)
Figure Merck Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Astra Zeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astra Zeneca Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Astra Zeneca Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Astra Zeneca Antihypertensive Drugs Production Market Share (2012-2017)
Figure Astra Zeneca Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Daiichi Sankyo Antihypertensive Drugs Production Market Share (2012-2017)
Figure Daiichi Sankyo Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Antihypertensive Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Takeda Antihypertensive Drugs Production Growth Rate (2012-2017)
Figure Takeda Antihypertensive Drugs Production Market Share (2012-2017)
Figure Takeda Antihypertensive Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihypertensive Drugs
Figure Manufacturing Process Analysis of Antihypertensive Drugs
Figure Antihypertensive Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2016
Table Major Buyers of Antihypertensive Drugs
Table Distributors/Traders List
Figure Global Antihypertensive Drugs Capacity, Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Antihypertensive Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Antihypertensive Drugs Production (K MT) Forecast by Region (2017-2022)
Figure Global Antihypertensive Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Antihypertensive Drugs Consumption (K MT) Forecast by Region (2017-2022)
Figure Global Antihypertensive Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Antihypertensive Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure North America Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Antihypertensive Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Europe Antihypertensive Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Antihypertensive Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure China Antihypertensive Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure China Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Antihypertensive Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Japan Antihypertensive Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Antihypertensive Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Southeast Asia Antihypertensive Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Antihypertensive Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure India Antihypertensive Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
Figure India Antihypertensive Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Antihypertensive Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Table Global Antihypertensive Drugs Production (K MT) Forecast by Type (2017-2022)
Figure Global Antihypertensive Drugs Production (K MT) Forecast by Type (2017-2022)
Table Global Antihypertensive Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Antihypertensive Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Antihypertensive Drugs Price Forecast by Type (2017-2022)
Table Global Antihypertensive Drugs Consumption (K MT) Forecast by Application (2017-2022)
Figure Global Antihypertensive Drugs Consumption (K MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Global Lercanidipine (API) Market Outlook 2017-2022
    Published: 08-Nov-2017        Price: US 2800 Onwards        Pages: 99
    Lercanidipine is an antihypertensive (blood pressure lowering) drug. It belongs to the dihydropyridine class of calcium channel blockers, which work by relaxing and opening the blood vessels allowing the blood to circulate more freely around the body. This lowers the blood pressure and allows the heart to work more efficiently. Lercanidipine is used for the treatment of essential hypertension (high blood pressure). The report covers forecast and analysis for the lercanidipine mark......
  • Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Pulmonary Arterial Hypertension - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Pulmonary Arterial Hypertension for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Pulmonary Arterial ......
  • Pulmonary Arterial Hypertension - Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Pulmonary Arterial Hypertension -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Pulmonary Arterial Hypertension in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Pulmonary Arterial Hypertension. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Pulmonary Arterial Hypert......
  • Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2250 Onwards        Pages: 120
    DelveInsight's, Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Pulmonary Arterial Hypertension. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for P......
  • Global Hypertension Partnering 2010 to 2017
    Published: 01-Nov-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understandi......
  • Portal Hypertension - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Portal Hypertension-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Portal Hypertension. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Portal Hypertension by development stage, therapy type, route of administration and molecule type is also covered in the report. I......
  • Pulmonary Arterial Hypertension - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 70
    DelveInsight's, "Pulmonary Arterial Hypertension-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Pulmonary Arterial Hypertension. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Pulmonary Arterial Hypertension by development stage, therapy type, route of administration and molecule t......
  • Anti-hypertension -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Anti-hypertension - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Anti-hypertension in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Anti-hypertension prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with th......
  • Resistant Hypertension - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Resistant Hypertension-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Resistant Hypertension. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Resistant Hypertension by development stage, therapy type, route of administration and molecule type is also covered in the ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs